Ahmed M. Bayoumi




Dr. Ahmed Bayoumi is a Scientist at MAP Centre for Urban Health Solutions at the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, where he is also a general internist and Human Immunodeficiency Virus (HIV) physician. He holds the Fondation Baxter and Alma Ricard Chair in Inner City Health at St. Michael’s Hospital and the University of Toronto and is a Professor in the Department of Medicine and in the Institute of Health Policy, Management and Evaluation at the University of Toronto. He is a Senior Adjunct Scientist at ICES. He has extensive experience in translating research to policy (member of the Canadian Drug Expert Committee, past Scientific Director of Converge3, past president of the international Society for Medical Decision Making, and past Director of Clinical Epidemiology and Health Care Research at the University of Toronto). He has co-led large multi-method studies, including the highly impactful Toronto and Ottawa Supervised Consumption Assessment (TOSCA) and the Marginalization and COVID-19 (MARCO) studies. His research interests include the delivery of health services, particularly to people who use drugs, people living with HIV, and other marginalized populations. He is a member of HMRAC (the Homelessness, Mortality, Research and Advocacy Coalition), an academic – community collaboration that meets regularly to discuss how research can address issues related to homelessness.

Recent Publications

  1. Ahmed, AF, Sharkawi, SS, AbdelHameed, SS, Bayoumi, AM, Moussa, RS, Alhakamy, NA et al.. Corrigendum to "Ketogenic diet restores hormonal, apoptotic/proliferative balance and enhances the effect of metformin on a letrozole-induced polycystic ovary model in rats" [Life Sci. 313 (2022) 121285]. Life Sci. 2023; :121829. doi: 10.1016/j.lfs.2023.121829. PubMed PMID:37271624 .
  2. Mahmoud Refaie, MM, Ahmed Rifaai, R, Bayoumi, AMA, Shehata, S. Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways. J Pharm Pharmacol. 2023; :. doi: 10.1093/jpp/rgad049. PubMed PMID:37262315 .
  3. Bayoumi, AMA, Ismail, MAM, Mahmoud, SS, Soliman, ASA, Mousa, AMA, Yousof, HSA et al.. The potential curative and hepatoprotective effects of platelet rich plasma on liver fibrosis in Schistosoma mansoni experimentally infected mice. J Parasit Dis. 2023;47 (2):349-362. doi: 10.1007/s12639-023-01576-9. PubMed PMID:37193508 PubMed Central PMC10182195.
  4. Bayoumi, AM. Quantitative Assessment of Parent and Patient Preferences. JAMA Netw Open. 2023;6 (5):e2313509. doi: 10.1001/jamanetworkopen.2023.13509. PubMed PMID:37184841 .
  5. Butler, A, Croxford, R, Bodkin, C, Akbari, H, Bayoumi, AM, Bondy, SJ et al.. Burden of opioid toxicity death in the fentanyl-dominant era for people who experience incarceration in Ontario, Canada, 2015-2020: a whole population retrospective cohort study. BMJ Open. 2023;13 (5):e071867. doi: 10.1136/bmjopen-2023-071867. PubMed PMID:37164452 PubMed Central PMC10186413.
  6. Tricco, AC, Parker, A, Hezam, A, Nincic, V, Yazdi, F, Lai, Y et al.. Controlled-release hydromorphone and risk of infection in adults: a systematic review. Harm Reduct J. 2023;20 (1):60. doi: 10.1186/s12954-023-00788-9. PubMed PMID:37118805 PubMed Central PMC10142404.
  7. O'Brien, KK, Erlandson, KM, Brown, DA, Carusone, SC, Vera, JH, Bergin, C et al.. Episodic Disability Questionnaire (EDQ) measurement properties among adults living with HIV in Canada, Ireland, United Kingdom, and United States. Res Sq. 2023; :. doi: 10.21203/rs.3.rs-2758163/v1. PubMed PMID:37066168 PubMed Central PMC10104244.
  8. O'Brien, KK, Ibáñez-Carrasco, F, Carusone, SC, Bayoumi, AM, Tang, A, McDuff, K et al.. Piloting an online telecoaching community-based exercise intervention with adults living with HIV: protocol for a mixed-methods implementation science study. BMJ Open. 2023;13 (3):e067703. doi: 10.1136/bmjopen-2022-067703. PubMed PMID:36997255 PubMed Central PMC10069544.
  9. Mighton, C, Clausen, M, Shickh, S, Baxter, NN, Scheer, A, Sebastian, A et al.. How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey. Genet Med. 2023;25 (5):100819. doi: 10.1016/j.gim.2023.100819. PubMed PMID:36919843 .
  10. Saunders, H, Anderson, C, Feldman, F, Holroyd-Leduc, J, Jain, R, Liu, B et al.. Developing a fall prevention intervention economic model. PLoS One. 2023;18 (1):e0280572. doi: 10.1371/journal.pone.0280572. PubMed PMID:36706109 PubMed Central PMC9882648.
Search PubMed

Affiliations & Other Activities

  • Scientist, MAP Centre for Urban Health Solutions, St. Michael’s Hospital
  • Professor, Department of Medicine, University of Toronto
  • Professor, Institute of Health Policy, Management and Evaluation, University of Toronto